皮肤T细胞淋巴瘤的新非化疗治疗选择 更新
Tarsheen Sethi1, Amrita Goyal-O'Leary2, Suzanne Xu3
1Hematology and Stem Cell Transplantation, Yale University School of Medicine, New Haven, CT, USA.
Expert review of anticancer therapy
|July 9, 2025
概括
新型非化疗治疗,包括向疗法和免疫疗法,为患有真菌菌菌病 (MF) 和塞萨里综合征 (SS) 的患者提供了更好的疗效和生活质量. 这些先进的选择解决了治疗这些T细胞淋巴瘤的挑战.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 菌根性菌病 (MF) 和塞萨里综合征 (SS) 是侵袭性T细胞淋巴瘤,影响皮肤,通常需要多种治疗线.
- 由于皮肤,淋巴结和血液的不同反应,目前的治疗方法面临挑战.
- 疾病生物学方面的进步正在为更有效的疗法铺平道路.
研究的目的:
- 对MF/SS.的新生物药物的临床数据进行审查.
- 讨论免疫治疗方法,包括CAR-T和双特异性抗体.
- 突出非化疗选择,以改善患者的治疗结果.
主要方法:
- 对新生物制剂的临床试验数据的审查.
- 对向治疗方法的分析,如布伦图西马布维多丁,拉库塔马布,德尼卢金二托克斯和莫加穆利祖马布.
- 探索免疫治疗策略,包括CAR-T和双特异性抗体.
主要成果:
- 向疗法在注册试验中表现出显著的活性.
- 正在研究调节瘤微环境和免疫反应的新型药物.
- 检查点抑制剂在MF/SS中的作用需要进一步定义.
结论:
- 对于MF/SS患者,由于皮肤完整性受到损害,非化疗选择是首选的.
- 新兴疗法在复发性/耐药性疾病中改善疗效和生活质量方面显示出前景.
- 对新生物药和免疫疗法的持续研究对于推进MF/SS治疗至关重要.
关键词:
皮肤T细胞淋巴瘤布伦图西马布 (brentuximab) 在维多丁中被发现.免疫疗法 免疫疗法您可以使用Mogamulizumab.菌菌病 菌病 菌病摄影场景的光.塞萨里综合征是什么 塞萨里综合征更多相关视频
06:51Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
15.3K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.5K
相关概念视频
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)